Key Highlights

  • Arbutus Biopharma announced a modified Dutch auction tender offer to buy back as much as $230 million in common stock.
  • The tender Offer Price range is $5.00 to $5.75 per share.
  • The move leverages cash reserves to execute a significant Capital return and decrease outstanding shares.
  • J.P. Morgan will serve as dealer-manager, with the offer anticipated to commence on or about August 24, 2026.

Arbutus Biopharma Corporation (NASDAQ: ABUS) announced a modified Dutch auction tender offer to buy back as much as $230 million in common stock at a price range of $5.00 to $5.75 per share.

What Happened

The move leverages the company's cash reserves to execute a significant capital return and decrease outstanding shares. J.P. Morgan will serve as the dealer-manager for the initiative, which is anticipated to commence on or about August 24, 2026.

Market Reaction

The disclosed information does not include stock price or trading data for Arbutus Biopharma following the tender offer announcement.

Outlook

The commencement of the tender offer on or about August 24, 2026 represents the next disclosed step for Arbutus Biopharma's capital return program.